14-day Premium Trial Subscription Try For FreeTry Free
$0.396
+0.0060 (+1.54%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.371 $0.93 Wednesday, 1st May 2024 SNGX stock ended at $0.396. This is 1.54% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.08% from a day low at $0.390 to a day high of $0.410.
90 days $0.371 $0.93
52 weeks $0.371 $4.20

Historical Soligenix, Inc prices

Date Open High Low Close Volume
Feb 20, 2024 $0.710 $0.720 $0.689 $0.720 63 535
Feb 16, 2024 $0.730 $0.730 $0.689 $0.689 58 828
Feb 15, 2024 $0.680 $0.750 $0.680 $0.728 89 592
Feb 14, 2024 $0.660 $0.700 $0.635 $0.696 102 718
Feb 13, 2024 $0.680 $0.693 $0.633 $0.663 162 277
Feb 12, 2024 $0.660 $0.730 $0.660 $0.700 137 574
Feb 09, 2024 $0.639 $0.689 $0.620 $0.679 45 928
Feb 08, 2024 $0.598 $0.650 $0.598 $0.648 95 184
Feb 07, 2024 $0.610 $0.620 $0.593 $0.614 69 544
Feb 06, 2024 $0.601 $0.630 $0.600 $0.610 117 364
Feb 05, 2024 $0.640 $0.660 $0.630 $0.648 29 030
Feb 02, 2024 $0.670 $0.670 $0.622 $0.659 197 774
Feb 01, 2024 $0.681 $0.682 $0.650 $0.670 71 299
Jan 31, 2024 $0.630 $0.670 $0.590 $0.670 111 088
Jan 30, 2024 $0.630 $0.642 $0.618 $0.639 64 527
Jan 29, 2024 $0.610 $0.660 $0.600 $0.640 103 429
Jan 26, 2024 $0.581 $0.628 $0.581 $0.610 97 885
Jan 25, 2024 $0.608 $0.609 $0.572 $0.595 81 561
Jan 24, 2024 $0.600 $0.630 $0.570 $0.590 123 472
Jan 23, 2024 $0.620 $0.620 $0.582 $0.618 180 095
Jan 22, 2024 $0.578 $0.610 $0.570 $0.600 131 019
Jan 19, 2024 $0.621 $0.621 $0.556 $0.574 366 666
Jan 18, 2024 $0.660 $0.663 $0.617 $0.621 153 113
Jan 17, 2024 $0.710 $0.720 $0.617 $0.634 404 326
Jan 16, 2024 $0.780 $0.790 $0.700 $0.710 539 243
Click to get the best stock tips daily for free!

About Soligenix, Inc

Soligenix Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ... SNGX Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT